Arkolith/Insider Trading/VIRX/Form 4

Chevallard Daniel R.

CFO and COOViracta Therapeutics, Inc. (VIRX) · full profile →Form 4 · filed Feb 28, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6K
Net Open-Market Flow
-$6K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 27, 2023Sell(S)4K$1.68$6K89K
Feb 25, 2023Option exercise(M)7K—$093K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 25, 2023Option exercise(M)7K—$062K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-013854) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML